J Jaime Caro

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Venues

PharmacoEconomics

Cancers

Orphanet journal of rare diseases

Stroke

Massachusetts College of Pharmacy and Health Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Massachusetts College of Pharmacy and Health Sciences

United States

Adj Professor

Thomas Jefferson University

United States

Lecturer :: Population Health

McGill University

Canada

Adj professor :: Epidemiology and Biostatistics

London School of Economics Department of Economics Jun 01 2018

United Kingdom

Professor in Practice :: Health Policy

Evidera Jan 01 1989

United States

Chief Scientist

Publications

Matthias Boentert, Kenneth I Berger, Jordi Díaz-Manera, Mazen M Dimachkie, Alaa Hamed, Lionel Riou França, Nathan Thibault, Pragya Shukla, Jack Ishak, J Jaime Caro
Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe disease. Orphanet journal of rare diseases 19 (1) (2024)
Matthias Boentert, Kenneth I Berger, Jordi Díaz-Manera, Mazen M Dimachkie, Alaa Hamed, Lionel Riou França, Nathan Thibault, Pragya Shukla, Jack Ishak, J Jaime Caro
Applying the win ratio method in clinical trials of orphan drugs: an analysis of data from the COMET trial of avalglucosidase alfa in patients with late-onset Pompe disease. Orphanet journal of rare diseases 19 (1) (2024)
Brandon Wen Bing Chua, Li Min Lim, Joseph Soon Yau Ng, Yan Ma, Hwee Lin Wee, J Jaime Caro
Correction: Chua et al. Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore. Cancers 2023, 15 , 1812. Cancers 15 (18) (2023)
Brandon Wen Bing Chua, Li Min Lim, Joseph Soon Yau Ng, Yan Ma, Hwee Lin Wee, J Jaime Caro
Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore. Cancers 15 (6) (2023)
Brandon Wen Bing Chua, Li Min Lim, Joseph Soon Yau Ng, Yan Ma, Hwee Lin Wee, J Jaime Caro
Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore. Cancers 15 (6) (2023)
Asmir Vodencarevic, Michael Weingärtner, J Jaime Caro, Dubravka Ukalovic, Marcus Zimmermann-Rittereiser, Stefan Schwab, Peter L Kolominsky-Rabas
Prediction of Recurrent Ischemic Stroke Using Registry Data and Machine Learning Methods: The Erlangen Stroke Registry. Stroke 53 (7) (2022)
J Jaime Caro
Best Practices: A Collection of Systematic Critical Reviews of Modeling Approaches in Specific Disease Areas. PharmacoEconomics (2022)
Ágnes Benedict, Emily R Hankosky, Kinga Marczell, Jieling Chen, David J Klein, J Jaime Caro, Jay P Bae, Brian D Benneyworth
A Framework for Integrating Continuous Glucose Monitor-Derived Metrics into Economic Evaluations in Type 1 Diabetes. PharmacoEconomics 40 (8) (2022)
Anuraag R Kansal, Odette S Reifsnider, Sarah B Brand, Neil Hawkins, Anna Coughlan, Shujun Li, Lael Cragin, Clark Paramore, Andrew C Dietz, J Jaime Caro
Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia. Journal of market access & health policy 9 (1) (2021)
Paul Tappenden, J Jaime Caro
Improving Transparency in Decision Models: Current Issues and Potential Solutions. PharmacoEconomics 37 (11) (2020)
J Jaime Caro
Discretely Integrated Condition Event (DICE) Simulation for Pharmacoeconomics. PharmacoEconomics 34 (7) (2017)

J Jaime Caro.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

J Jaime Caro